Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 1836 News Items found The History and Future of Cancer Vaccines at MSK Friday, June 6, 2025 Learn about MSK’s leadership in developing vaccines that teach the immune system to fight cancer. The Latest Advances in Lung Cancer Care at MSK: Improving Detection and Survival Rates Friday, June 6, 2025 Learn how MSK experts are improving the detection and treatment of lung cancer, from fundamental questions of the disease biology to new screening and therapy options. The Next Frontier of Precision Diagnostics in Cancer Care Friday, June 6, 2025 Since the launch of the Center for Molecular Oncology a decade ago, scientists and doctors at MSK have been leaders in the field of personalized oncology. The Next Generation of Cancer Researchers: Brandon Cuevas Friday, June 6, 2025 Meet Cancer Engineering MD-PhD candidate Brandon Cuevas: “Being able to be a bridge between medicine and research is such a privilege, one that not many places can offer.” The Society of Memorial Sloan Kettering 2024 Friday, June 6, 2025 The Society of Memorial Sloan Kettering Cancer Center (MSK), composed of more than 120 philanthropist volunteers dedicated to MSK’s mission, raised an ... Q&A What To Know About Pancreatic Cancer Thursday, June 5, 2025 Learn about important advances in the treatment of pancreatic cancer. Q&A CT Scan vs. MRI: What’s the Difference? Wednesday, June 4, 2025 Learn the difference between CT Scan and MRI and how doctors use these imaging techniques to diagnose and stage cancer. Lung Cancer Treatment Advances from MSK Presented at 2025 ASCO Meeting Monday, June 2, 2025 New findings on several important lung cancer clinical trials were presented at the 2025 Annual Meeting of the American Society of Clinical Oncology. Study Provides New Insights Into the Genetic Complexity of Cancer Metastasis Monday, June 2, 2025 A new study from researchers at MSK and Weill Cornell Medicine provides fresh insights about how cancers evolve when they metastasize — insights that could aid in developing strategies to improve the effectiveness of treatment. Article New Drug Combination Improves Survival for ER+, HER2- Breast Cancer Saturday, May 31, 2025 Learn about a three-drug treatment that has been shown to extend survival for ER+, HER2- breast cancers. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment